[1]
N. Moryl, MD, “Successful use of buprenorphine-naloxone medication-assisted program to treat concurrent pain and opioid addiction after cancer therapy”, J of Opioid Management, vol. 16, no. 2, pp. 111–118, Mar. 2020.